Serum insulin, insulin resistance, β-cell dysfunction, and gallstone disease among type 2 diabetics in Chinese population: A community-based study in Kinmen, Taiwan

World Journal of Gastroenterology

Volumn 11, Issue 45, 2005, Pages 7159-7164

  Liu, Chih Ming ^a   Tung, Tao Hsin ^a   Tsai, Shih Tzer ^b   Liu, Jorn Hon ^a   Tsai, Yeh Kuang ^c   Chen, Victor Tze Kai ^d   Tam, Tseng Nip ^e   Lu, Hsu Feng ^e   Wang, Kuang Kuo ^e   Hsu, Chung Te ^e   Shih, Hui Chuan ^f   Chan, De Chuan ^g   Chou, Pesus ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^f KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^g TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Community based study; Gallstone disease; Insulin resistance; Type 2 diabetes; cell dysfunction

Indexed keywords

INSULIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; B LYMPHOCYTE; CHINESE; CHOLELITHIASIS; CLINICAL OBSERVATION; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT IDENTIFICATION; POPULATION RESEARCH; PREVALENCE; QUANTITATIVE ANALYSIS; REAL TIME ECHOGRAPHY; RISK ASSESSMENT; SCREENING TEST; SEX RATIO; TAIWAN;

EID: 31544440422     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i45.7159     Document Type: Article

References (35)

1. de Leon MP, Ferenderes R, Carulli N. Bile lipid composition and bile acid pool size in diabetes. Am J Dig Dis 1978; 23: 710-716
2. Shaw SJ, Hajnal F, Lebovitz Y, Ralls P, Bauer M, Valenzuela J, Zeidler A. Gallbladder dysfunction in diabetes mellitus. Dig Dis Sci 1993; 38: 490-496
3. Haffner SM, Diehl AK, Valdez R, Mitchell BD, Hazuda HP, Morales P, Stern MP. Clinical gallbladder disease in NIDDM subjects. Relationship to duration of diabetes and severity of glycemia. Diabetes Care 1993; 16: 1276-1284
4. De Santis A, Attili AF, Ginanni Corradini S, Scafato E, Cantagalli A, De Luca C, Pinto G, Lisi D, Capocaccia L. Gallstones and diabetes: A case-control study in a free-living population sample. Hepatology 1997; 25: 787-790
5. Liu CM, Tung TH, Liu JH, Lee WL, Chou P. A community-based epidemiology study on gallstone disease among type 2 diabetics in Kinmen, Taiwan. Dig Dis 2004; 22: 87-91
6. Reaven GM. Banting lecture-1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607
7. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003; 26: 3320-3325
8. Rojo-Martinez G, Esteva I, de Adana SR, Catala M, Merelo MJ, Tinahones F, Gomez-Zumaquero JM, Cuesta AL, Cardona F, Soriguer F. Patterns of insulin resistance in the general population of southeast Spain. Diabetes Res Clin Pract 2004; 65: 247-256
9. Kahn SE. The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus. Am J Med 2000; 108 Suppl 6a: 2S-8S
10. Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 1998; 19: 477-490
11. Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykkanen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996; 45: 742-748
12. Li CL, Tsai ST, Chou P. Relative role of insulin resistance and bata-cell dysfunction in the progression to type 2 diabetes - The Kinmen Study. Diabetes Res Clin Pract 2003; 59: 225-232
13. Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology 2000; 31: 299-303
14. Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodriguez G, Baptista H, Ramos MH, Uribe M. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005; 11: 1653-1657
15. Chou P, Liao MJ, Kuo HS, Hsiao KJ, Tsai ST. A population survey on the prevalence of diabetes in Kin-Hu, Kinmen. Diabetes Care 1994; 17: 1055-1058
16. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Organization, 1985 (Tech. Rep. Ser., no.727).
17. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1 Diagnosis and classification of diabetes mellitus. Geneva, World Health Organization 1999
18. Liu CM, Tung TH, Liu JH, Chen VT, Lin CH, Hsu CT, Chou P. A community-based epidemiological study of elevated serum alanine aminotransferase levels in Kinmen, Taiwan. World J Gastroenterol 2005; 11: 1616-1622
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
20. Mendez-Sanchez N, Cardenas-Vazquez R, Ponciano-Rodriguez G, Uribe M. Pathophysiology of cholesterol gallstone disease. Arch Med Res 1996; 27: 433-441
21. Chen CY, Lu CL, Lee PC, Wang SS, Chang FY, Lee SD. The risk factors for gallstone disease among senior citizens: an Oriental study. Hepatogastroenterology 1999; 46: 1607-1612
22. Bouchier IAD. Gallstones: formation and epidemiology. In: Blumgart LH ed. Surgery of the liver and biliary tract. Edinburgh: Churchill linvingstone, 1998: pp503-516.
23. Pacchioni M, Nicoletti C, Caminiti M, Calori G, Curci V, Camisasca R, Pontiroli AE. Association of obesity and type II diabetes mellitus as a risk factor for gallstones. Dig Dis Sci 2000; 45: 2002-2006
24. Kodama H, Kono S, Todoroki I, Honjo S, Sakurai Y, Wakabayashi K, Nishiwaki M, Hamada H, Nishikawa H, Koga H, Ogawa S, Nakagawa K. Gallstone disease risk in relation to body mass index and waist-to-hip ration in Japanese men. Int J Obes Relat Metab Disord 1999; 23: 211-216
25. Kono S, Shinchi K, Todoroki I, Honjo S, Sakurai Y, Wakabayashi K, Imanishi K, Nishikawa H, Ogawa S, Katsurada M. Gallstone disease among Japanese men in relation to obesity, glucose intolerance, exercise, alcohol use, and smoking. Scand J Gastroenterol 1995; 30: 372-376
26. Heaton KW, Braddon FE, Emmett PM, Mountford RA, Hughes AP, Bolton CH. Why do men get gallstones? Roles of abdominal fat and hyperinsulinemia. Eur J Gastroenterol Hepatol 1991; 3: 745-751
27. Jorgensen T. Gall stones in a Danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus. Gut 1989; 30: 528-534
28. Maurer KR, Everhart JE, Knowler WC, Shawker TH, Roth HP. Risk factors for gallstone disease in the Hispanic populations of the United States. Am J Epidemiol 1990; 131: 836-844
29. Misciagna G, Guerra V, Di Leo A, Correale M, Trevisan M. Insulin and gall stones: a population case control study in southern Italy. Gut 2000; 47: 144-147
30. Hahm JS, Park JY, Park KG, Ahn YH, Lee MH, Park KN: Gallbladder motility in diabetes mellitus using real time ultrasonography. Am J Gastroenterol 1996; 91: 2391-2394
31. Gielkens HA, Lam WF, Coenraad M, Frolich M, van Oostayen JA, Lamers CB, Masclee AA. Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans. J Hepatol 1998; 28: 595-602
32. Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 2004; 53: 250-64
33. Toffolo G, De Grandi F, Cobelli C. Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion. Diabetes 1995; 44: 845-854
34. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T, Shoji T, Okuno Y, Morii H. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999; 22: 818-822
35. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63